Paroxetin in the treatment of agoraphobia and alcohol dependency;Paroxetin in der Therapie der Agoraphobie und Alkoholabhangigkeit

Nervenheilkunde

Volumn 16, Issue 7, 1997, Pages 412-416

  Boerner, R J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

agoraphobia; alprazolam; comorbidity; panic disorder; paroxetin

Indexed keywords

ALPRAZOLAM; IMIPRAMINE; PAROXETINE;

ADULT; AGORAPHOBIA; ALCOHOLISM; ANXIETY; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; PSYCHOTHERAPY;

EID: 0030767429     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Asnis M, van Praag HM. Panic disorder. Clinical, biological and treatment aspects. The Einstein Psychiatry Series. New York: Wiley, 1995.
2. Ballenger JC. Overview of the pharmacotherapy of panic disorder. In: Treatment of panic disorder. A consensus development conference. Wolfe BE, Maser JD. Washington: AP Press, 1994; 59-73.
3. Bandelow B. The assessment of efficacy of treatments for panic disorder and agoraphobia II. The Panic and Agoraphobia Scale. International Clinical Psychopharmacology 1995; 10: 73-82.
4. Baving L, Olbrich H. Angst bei Alkoholabhängigen. Fortschr. Neurol. Psychiat. 1996; 64: 83-9.
5. Bibb JL, Chambless DL. Alcohol use and abuse among diagnosed agoraphobics. Behav. Res. Ther. 1986; 24: 49-58.
6. Boerner RJ, Möller HJ. Pharmakotherapie der Panikstörung und/oder Agoraphobie. Psychopharmakotherapie, 3. Jahrgang, Heft 4, 1996; 1-17.
7. Boerner RJ, Gülsdorff B, Margraf J, Osterheider M, Wittchen HU, Philipp M. Die Panikstörung - Diagnose und Behandlung, Schattauer Verlag 1996.
8. Boerner RJ, Möller HJ. The use of SSRIs in panic disorder. Journal of Psychiatry in Clinical Practice, 1997, in press.
9. Cowley DS. Alcohol abuse, substance abuse, and panic disorder. Am J Med 1992; 92: 1a: 41-8.
10. Cross-National Collaborative Panic Study. Drug treatment of refractory anxiety. J Clin Psychiatry 1994; 55: 2: 27-31.
11. Dunbar G, Steiner M, Oakes I, Gergel D, Burnham D, Wheadon DE. A fixed dose study of paroxetine (10 mg, 20 mg, 40 mg) and placebo in the treatment of panic disorder. ECNP 1995.
12. Lecrubier Y, Bakker A, Judge R. Comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. ECNP 1995.
13. Margraf J, Barlow DH, Clark DM, Telch MJ. Psychological treatment of panic. Work in Progress on outcome active Ingredients and follow-up. Behav Res Ther 1993; 31: 1-8.
14. Oehrberg S, Christiansen PE. A double-blind, randomized, multicentre, placebocontrolled study of paroxetine in combination with psychotherapy in the treatment of patients with panic disorder. British Journal of Psychiatry 1995; 167: 374-9.
15. Rosenbaum JR. Current issues in panic disorder. Presentation at the symposium APA-congress, New York, 1995.
16. Stravynski A, Lamontagne Y, Lavallee Y. Clinical phobias and avoidant personality disorder among alcoholics admitted to an alcoholism rehabilitation setting. Can J. psychiatry 1986; 31: 714-9.
17. Westenberg HGM. Ergebnisse einer multinationalen Placebo-kontrollierten Studie mit Clomipramin und Paroxetin in der Behandlung der Panikstörung. Vortrag
18. Symposium - European Facing Depression - des 7. AEP-Kongresses Kopenhagen. TW Neurologie/Psychiatrie Sonderdruck 1993; 128: 698.
19. Wittchen HU, Vossen A. Implikationen von Komorbidität bei Angststörungen - ein kritischer Überblick. Verhaltenstherapie 1995; 5: 120-33.
20. Wittchen HU, Perkkonigg A. Panikattacken mit frühem und späten Beginn: Unterschiedliche pathogenetische Mechanismen. Verhaltenstherapie 1993; 3: 296-303.
21. Wittchen HU. Der Langzeitverlauf unbehandelter Angststörungen: Wie häufig sind Spontanremissionen? Verhaltenstherapie 1991; 1: 273-83.
22. Wolfe BE, Maser JD. Treatment of panic disorder. A consensus development conference. Washington: AP Press 1994.